Literature DB >> 21772294

Therapeutic drug monitoring for mycophenolic acid is value for (little) money.

T van Gelder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21772294     DOI： 10.1038/clpt.2011.96

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.

Authors:  Teun van Gelder; Ron H van Schaik; Dennis A Hesselink
Journal:  Nat Rev Nephrol       Date:  2014-09-23       Impact factor: 28.314

Review 2.  Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

Review 3.  The influence of UGT polymorphisms as biomarkers in solid organ transplantation.

Authors:  Robert Dupuis; Andrea Yuen; Federico Innocenti
Journal:  Clin Chim Acta       Date:  2012-02-01       Impact factor: 3.786

4.  The inevitable QSAR renaissance.

Authors:  Richard D Cramer
Journal:  J Comput Aided Mol Des       Date:  2011-11-30       Impact factor: 3.686

Review 5.  Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention.

Authors:  David K Metz; Nick Holford; Joshua Y Kausman; Amanda Walker; Noel Cranswick; Christine E Staatz; Katherine A Barraclough; Francesco Ierino
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.